07:30 AM EDT, 08/13/2026 (MT Newswires) -- Leslie's (LESL) shares were down more than 42% premarket Thursday following the company's fiscal Q3 financial results.

Valion Bio ( VBIO ) stock was 30% lower, continuing from a 27% fall in the prior session. The company said Wednesday that the Armed Forces Radiobiology Research Institute initiated a US government-funded study evaluating its drug, Entolimod, for radiation-induced gastrointestinal injury.

Founder Group ( FGL ) shares were down 26% following a 3.2% gain in the previous session.

The company's subsidiary announced a new contract to build a 1.78 MW-peak rooftop solar system for an aquaculture shrimp farm in Kedah, Malaysia.

Netcapital ( NCPL ) stock was 25% lower after the company released an official CEO statement addressing the civil fraud complaint filed by the US Securities and Exchange Commission against the company and certain directors.

Outlook Therapeutics ( OTLK ) shares were down 24% pre-bell after it priced a public offering late Wednesday.